Subjective preference for lamotrigine or topiramate in healthy volunteers: Relationship to cognitive and behavioral functioning

Epilepsy and Behavior

Volumn 8, Issue 1, 2006, Pages 181-191

  Werz, Mary Ann ^a   Schoenberg, Mike R ^a   Meador, Kimford J ^b   Loring, David W ^b   Ray, Patty G ^c   Kaul Gupta, Rina ^c   Ogrocki, Paula ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cognition; Drug preference; Epilepsy health outcome; Lamotrigine; Mood; Topiramate

Indexed keywords

LAMOTRIGINE; TOPIRAMATE;

ADULT; AGE DISTRIBUTION; ANGER; ARTICLE; ATTENTION DISTURBANCE; BEHAVIOR DISORDER; BODY MASS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL OBSERVATION; CLINICAL TRIAL; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG PREFERENCE; DYSPHORIA; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE QUOTIENT; LANGUAGE DISABILITY; MALE; MEMORY DISORDER; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NORMAL HUMAN; PROFILE OF MOOD STATES; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SELF CONCEPT; SELF REPORT; SEX DIFFERENCE; SIDE EFFECT; VOLUNTEER;

ADULT; ANTICONVULSANTS; ATTENTION; BEHAVIOR; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT SATISFACTION; QUALITY OF LIFE; TRIAZINES;

EID: 30844450089     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2005.09.003     Document Type: Article

References (57)

1. P. Kwan M.K. Brodie Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy Neurology 60 Suppl. 4 2003 S2-S12
2. F. Gilliam R. Kuzniecky E. Faught et al Patient-validated content of epilepsy specific quality of life measurement Epilepsia 38 1997 233-236
3. G.A. Baker A. Jacoby D. Buck et al Quality of life of people with epilepsy: A European study Epilepsia 38 1997 353-362
4. R.S. Fisher B.G. Vickrey P. Gibson et al The impact of epilepsy from the patient's perspective: II. Views about therapy and health care Epilepsy Res 41 2000 53-61
5. International Bureau for Epilepsy. Cognitive Function survey. 2004. Available from: http://ibe-epilepsy.org/uploadimages/ IBE%20Epilepsy%20and%20CognitiveFunctionResults.pdf.
6. F. Gilliam Optimizing health outcomes in active epilepsy Neurology 58 2002 S9-S20
7. A. Kanner Depression in epilepsy: Prevalence, clinical semiology, pathogenic mechanisms, and treatment Biol Psychiatry 54 2003 388-398
8. A. Kanner Depression in epilepsy: A frequently neglected multifaceted disorder Epilepsy Behav 4 2003 s11-s19
9. L.S. Boylan O. Devinsky J.J. Barry T.A. Ketter Psychiatric uses of anti-epileptic treatments Epilepsy Behav 3 2002 S54-S59
10. S. Stahl Anticonvulsants as mood stabilizers and adjuncts to anti-psychotics: Valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels J Clin Psychiatry 56 2004 738-739
11. C.M. Clancy J.M. Eisenberg Outcomes research: Measuring the end results of health care Science 282 1998 245-246
12. J.J. Barry A. Lembke K.D. Bullock Current status of the utilization of antiepileptic treatments in mood, anxiety, and aggression: Drugs and devices Clin EEG Neurosci 2004 4-13
13. K.J. Meador D.W. Loring V.J. Vahle et al Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers Neurology 64 2005 2108-2114
14. M.J. Brodie A. Richens A.W.C. Yuen Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy Lancet 345 1995 476-479
15. F.G. Gilliam F. Veloso M.A. Bomhof et al A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy Neurology 60 2003 196-202
16. J. Waugh K.L. Goa Topiramate as monotherapy in newly diagnosed epilepsy CNS Drugs 17 2003 985-992
17. L.M. Dunn L.M. Dunn Peabody Picture Vocabulary Test 3rd ed. 1997 American Guidance Service Circle Pines, MN
18. K.J. Meador D.W. Loring M.E. Allen et al Comparative cognitive effects of carbamazepine and phenytoin in healthy adults Neurology 41 1991 1537-1540
19. K.J. Meador D.W. Loring O.L. Abney et al Effects of carbamazepine and phenytoin on EEG and memory in healthy adults Epilepsia 34 1993 153-165
20. K.J. Meador D.W. Loring E.E. Moore et al Comparative cognitive effects of phenobarbital, phenytoin and valproate in healthy subjects Neurology 45 1995 1494-1499
21. K.J. Meador D.W. Loring P.G. Ray et al Differential cognitive and behavioral effects of carbamazepine and lamotrigine Neurology 8 2001 1177-1182
22. P.G. Ray K.J. Meador D.W. Loring E.Y. Zamrini X.H. Yang J.J. Buccafusco Central anticholinergic hypersensitivity in aging J Geriatr Psychiatr Neurol 5 1992 7277
23. C.B. Dodrill J.L. Arnett K.W. Sommerville N.M. Sussman Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy Epilepsia 36 1995 164-173
24. H. Buschke P.A. Fuld Evaluating storage, retention, and retrieval in disordered memory and learning Neurology 24 1974 1019-1025
25. O. Spreen E. Strauss A compendium of neuropsychological tests: administration norms and commentary 1998 Oxford Univ. Press New York
26. E. Kaplan H. Goodglass S. Weintraub The Boston naming test 1983 Lea & Febiger Philadelphia
27. J.D. Henry J.R. Crawford A meta-analytic review of verbal fluency performance following cortical lesions Neuropsychology 18 2004 284-295
28. M.D. Lezak Neuropsychological assessment 3rd ed. 1995 Oxford Univ Press New York
29. R. Lachman J.L. Lachman E.C. Butterfield Cognitive psychology and information processing: An introduction 1979 Lawrence Erlbaum Hillsdale, NJ
30. C.J. Golden Stroop Color and Word Test: A manual for clinical and experimental uses 1978 Stoelting Chicago
31. A. Smith Symbol Digit Modalities Test: Manual 1973 Western Psychological Services Los Angeles
32. A.P. Aldenkamp G. Baker M.S. Pieters H.C. Schoemaker A.F. Cohen S. Schwabe The Neurotoxicity Scale: The validity of a patient-based scale assessing neurotoxicity Epilepsy Res 20 1995 229-239
33. L. Abbetz A. Jacoby G.A. Baker P. McNulty Patient based assessments of quality of life in newly diagnosed epilepsy patients: Validation of the NEWQOL Epilepsia 41 2000 1119-1128
34. M. Lorr D.M. McNair L.F. Droppleman Manual: Profile of mood states 1971 Educational and Industrial Testing Service San Diego, CA
35. O. Devinsky B.G. Vickrey J. Cramer et al Development of the Quality of Life in Epilepsy (QOLIE) Inventory Epilepsia 36 1995 1089-1104
36. R. Gillham G. Baker P. Thompson et al Standardization of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments Epilepsy Res 24 1996 47-55
37. R. Gillham L. Bryant-Comstock K. Kane Validation of the side effect and life satisfaction (SEALS) inventory Seizure 9 2000 458-463
38. J.E. Ware M. Kosinski S.D. Keller A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 34 1996 220-233
39. L.J. Hirsch D. Weintraub Y. Du et al Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy Neurology 63 2004 1022-1026
40. W. Fröscher F. Keller H. Vogt G. Krämer Prospective study on concentration-efficacy and concentration-toxicity: Correlations with lamotrigine serum levels Epileptic Disord 4 2002 49-56
41. R.E. Twyman E. Ben-Menachem F. Veloso et al Plasma topiramate (TPM) concentration vs. therapeutic response during monotherapy Epilepsia 40 Suppl. 7 1999 111-112
42. F.G. Gillliam F. Veloso M.A.M. Bomhof et al A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy Neurology 60 2003 196-202
43. A.R. Ferrari R. Guerrini G. Gatti et al Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response Ther Drug Monit 25 2003 700-708
44. M.J. Hamilton A.F. Cohen A.W.C. Yuen et al Carbamazepine and lamotrigine in healthy volunteers: Relevance to early tolerance and clinical trial dosages Epilepsia 34 1993 166-173
45. A.P. Aldenkamp J. Arends H.P. Bootsma et al Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers Epilepsia 43 2002 19-26
46. R. Martin R. Kuzniecky H. Hetherington et al Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults Neurology 52 1999 321-327
47. T.J. Steiner C.I. Dellaportas et al Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin Epilepsia 40 1999 601-607
48. J.R. Calabrese T. Suppes C.L. Bowden et al A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group J Clin Psychiatry 61 2000 841-850
49. C.-G. Hahn L. Gyulai C.F. Baldassano R.H. Lenox The current understanding of lamotrigine as a mood stabilizer J Clin Psychiatry 65 2004 791-804
50. K.J. Meador F.G. Gilliam A.M. Kanner J.M. Pellock Cognitive and behavioral effects of anti-epileptic drugs Epilepsy Behav 2 2003 ss1-ss17
51. J.A. Cramer A.E. Hammer R.P. Kustra Improved mood states with lamotrigine in patients with epilepsy Epilepsy Behav 5 2004 702-707
52. A.P. Aldenkamp G. Baker O.G. Mulder et al A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures Epilepsia 41 2000 1167-1178
53. P.J. Thompson S.A. Baxendale J.S. Duncan J.W.A.S. Sander Effects of topiramate on cognitive function J Neurol Neurosurg Psychiatry 69 2000 636-641
54. S. Lee V. Sziklas F. Andermann et al The effects of adjunctive topiramate on cognitive function in patients with epilepsy Epilepsia 44 2003 339-347
55. K.J. Meador D.W. Loring et al Differential cognitive and behavioral effects of topiramate and valproate Neurology 60 2003 1483-1488
56. E. Kockelmann C.E. Elger C. Helmstaedter Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: Relationships to blood serum levels and comedication Epilepsy Behav 5 2004 716-721
57. K. Perrine B.P. Hermann K.J. Meador J.A. Vickrey R.D. Hays O. Devinsky The relationship of neuropsychological functioning to quality of life in epilepsy Arch Neurol 52 1993 997-1003